Excretion After oral dosing of radiolabeled methylphenidate in humans, about 90% on the radioactivity was recovered in urine. The primary urinary metabolite was ritalinic acid, accounting for roughly eighty% on the dose.Within a lifetime carcinogenicity review performed in B6C3F1 mice, methylphenidate prompted a rise in hepatocellular adenomas and,